- Home
- TPH vs CPRX Comparison
TPH vs CPRX Comparison
Compare TPH & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPH
- CPRX
- Stock Information
- Founded
- TPH 2009
- CPRX 2002
- Country
- TPH United States
- CPRX United States
- Employees
- TPH N/A
- CPRX N/A
- Industry
- TPH Homebuilding
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- TPH Consumer Discretionary
- CPRX Health Care
- Exchange
- TPH Nasdaq
- CPRX Nasdaq
- Market Cap
- TPH 2.9B
- CPRX 2.6B
- IPO Year
- TPH N/A
- CPRX 2006
- Fundamental
- Price
- TPH N/A
- CPRX $20.39
- Analyst Decision
- TPH Buy
- CPRX Strong Buy
- Analyst Count
- TPH 6
- CPRX 5
- Target Price
- TPH $41.20
- CPRX $33.20
- AVG Volume (30 Days)
- TPH 977.9K
- CPRX 1.6M
- Earning Date
- TPH 10-23-2025
- CPRX 11-05-2025
- Dividend Yield
- TPH N/A
- CPRX N/A
- EPS Growth
- TPH N/A
- CPRX 183.96
- EPS
- TPH 3.96
- CPRX 1.65
- Revenue
- TPH $4,041,885,000.00
- CPRX $558,499,000.00
- Revenue This Year
- TPH N/A
- CPRX $16.51
- Revenue Next Year
- TPH $1.33
- CPRX $9.58
- P/E Ratio
- TPH $8.17
- CPRX $12.38
- Revenue Growth
- TPH N/A
- CPRX 28.55
- 52 Week Low
- TPH $27.90
- CPRX $19.05
- 52 Week High
- TPH $46.91
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- TPH 35.46
- CPRX 56.67
- Support Level
- TPH $33.65
- CPRX $19.05
- Resistance Level
- TPH $34.96
- CPRX $21.22
- Average True Range (ATR)
- TPH 0.79
- CPRX 0.59
- MACD
- TPH -0.20
- CPRX 0.14
- Stochastic Oscillator
- TPH 3.53
- CPRX 56.81
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. The company's financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).